| 12116358 |
Substituted indoles and methods of use thereof |
John W. Lampe, John Emmerson Campbell, Kenneth W. Duncan, Megan Foley, Darren Harvey +2 more |
2024-10-15 |
|
| 11970485 |
RET kinase inhibitors |
Gabrielle R. Kolakowski, Erin Danielle ANDERSON, Steven W. Andrews, Christopher Pierre Albert Jean Boldron, Kevin Ronald Condroski +9 more |
2024-04-30 |
$5,266,524,000 |
| 11964968 |
Compounds useful for inhibiting RET kinase |
Erin Danielle ANDERSON, Steven W. Andrews, Kevin Ronald Condroski, Thomas Combs IRVIN, Gabrielle R. Kolakowski +4 more |
2024-04-23 |
$4,797,509,000 |
| 11697647 |
RET kinase inhibitors |
Gabrielle R. Kolakowski, Erin Danielle ANDERSON, Steven W. Andrews, Christopher Pierre Albert Jean Boldron, Kevin Ronald Condroski +9 more |
2023-07-11 |
$2,453,433,000 |
| 11613533 |
Compounds useful for inhibiting RET kinase |
Erin Danielle ANDERSON, Steven W. Andrews, Kevin Ronald Condroski, Thomas Combs IRVIN, Gabrielle R. Kolakowski +4 more |
2023-03-28 |
$1,082,597,000 |
| 10980794 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin |
2021-04-20 |
$11,349,000 |
| 10653693 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin, Elayne PENEBRE +1 more |
2020-05-19 |
$30,835,000 |
| 10577363 |
Substituted piperidine compounds |
Lorna Helen Mitchell, Andrew Simon Bell, Richard Chesworth, Megan Foley, Kevin Wayne Kuntz +1 more |
2020-03-03 |
$33,780,000 |
| 10428029 |
Isoxazole carboxamide compounds |
Megan Foley, Kevin Wayne Kuntz, James Edward John Mills, Lorna Helen Mitchell, Darren Harvey |
2019-10-01 |
$15,028,000 |
| 10391089 |
PRMT5 inhibitors and uses therof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin |
2019-08-27 |
$18,193,000 |
| 10307413 |
Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin |
2019-06-04 |
$18,492,000 |
| 10266526 |
Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer |
Megan Foley, Kevin Wayne Kuntz, James Edward John Mills, Lorna Helen Mitchell, Darren Harvey |
2019-04-23 |
$18,076,000 |
| 10150758 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth |
2018-12-11 |
$2,413,000 |
| 10118918 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin |
2018-11-06 |
$4,541,000 |
| 10106510 |
Substituted isoxazoles for treating cancer |
Megan Foley, Kevin Wayne Kuntz, Lorna Helen Mitchell |
2018-10-23 |
$10,045,000 |
| 9908887 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Lei Jin |
2018-03-06 |
$18,770,000 |
| 9777008 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Lei Jin |
2017-10-03 |
$6,594,000 |
| 9765068 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin |
2017-09-19 |
$9,397,000 |
| 9745291 |
PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin |
2017-08-29 |
$14,926,000 |
| 9732072 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin |
2017-08-15 |
$6,214,000 |
| 9675614 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin |
2017-06-13 |
$12,060,000 |
| 9611257 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth |
2017-04-04 |
$12,143,000 |
| 9604930 |
Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin |
2017-03-28 |
$13,781,000 |
| 9388173 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth, Lei Jin |
2016-07-12 |
$10,332,000 |
| 9365555 |
PRMT5 inhibitors and uses thereof |
Kenneth W. Duncan, Richard Chesworth |
2016-06-14 |
|
